Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0027960 (
mole
)
21,279
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
A significant portion of brain phosphatidylethanolamine (PE) is synthesized by a pathway involving the mitochondrial enzyme
phosphatidylserine decarboxylase
(
PSDC
), in a process by which phosphatidylserine (PS) is transferred from the endoplasmic reticulum to mitochondria. Aging changes the fatty acid composition of brain phospholipids, PS and PE being the most affected. The present study was carried out to determine
PSDC
activity in cerebral cortex (CC) and cerebellum (CRBL) mitochondrial fraction from adult (4-month-old) and aged (30-month-old) rats and to compare these activities with that found in liver. To study the effect of 22:6n-3 content on the
PSDC
activity, PSs from different sources were prepared: rPS (from bovine retina, containing 36 mol % of 22:6n-3); adPS (from adult rat CC microsomal membranes, with 25
mole
% 22:6n-3 content) and agPS (from aged rat CC microsomal membranes, with 21
mole
% 22:6n-3 content). For aged CC
PSDC
, the preferred substrate was agPS (the physiological substrate for aged animals), whereas in adult CC
PSDC
the substrate preference was inverse (rPS > adPS > agPS). Furthermore, CRBL
PSDC
does not show any substrate preference based on 22:6n-3 content. CRBL
PSDC
activity in aged membranes using agPS as substrate is lower than
PSDC
activity in adult membranes in the presence of adPS. These results indicate that under physiological conditions, cerebellar
PSDC
is inhibited during aging. Liver
PSDC
activity showed the same substrate preference in adult and aged rats as adult CC
PSDC
. These findings lead us to conclude that
PSDC
activity has a differential tissue-dependent substrate preference characteristic of the aging process.
...
PMID:Age-related changes in central nervous system phosphatidylserine decarboxylase activity. 1239 87